Filing Flows › Comparisons › BOLT vs SKVI
Bolt Biotherapeutics vs Skinvisible: BOLT and SKVI compared
Bolt Biotherapeutics is the larger company: $5K of revenue in its latest quarter (Q2 2026) against $5K for Skinvisible (Q2 2026). Skinvisible is growing faster (0% against -100% a year earlier).
Where the money goes: BOLT and SKVI
Bolt Biotherapeutics (BOLT) · Q2 2026
Bolt Biotherapeutics, Q2 2026: revenue $5K (-100% year over year), net loss $7.7M, operating cash flow −$6.5M. The chart follows the revenue to costs, profit and cash.
Skinvisible (SKVI) · Q2 2026
Skinvisible, Q2 2026: revenue $5K (0% year over year), net loss $256K, operating cash flow $2K. The chart follows the revenue to costs, profit and cash.
| Bolt Biotherapeutics (BOLT) | Skinvisible (SKVI) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $5K | $5K |
| Revenue growth, Y/Y | -100% | 0% |
| Operating margin | n/m | n/m |
| Net earnings | −$7.7M | −$256K |
| Operating cash flow | −$6.5M | $2K |
Questions
Which is bigger, Bolt Biotherapeutics or Skinvisible?
Bolt Biotherapeutics is the larger company: $5K of revenue in its latest quarter (Q2 2026) against $5K for Skinvisible (Q2 2026).
Is Bolt Biotherapeutics or Skinvisible growing faster?
Skinvisible is growing faster (0% against -100% a year earlier).
More: Bolt Biotherapeutics earnings · how Bolt Biotherapeutics makes money · Skinvisible earnings · how Skinvisible makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.